Eye Teaming Evaluation Study

This study has been completed.

Sponsored by:	Ohio State University
Information provided by:	Ohio State University
ClinicalTrials.gov Identifier:	NCT00472407

Purpose

Measurement of near point of convergence (NPC) is often critical to the diagnosis of CI. This study will evaluate NPC measurements with commonly used target types.

Condition	Intervention
Convergence Insufficiency	Device: NPC targets

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Active Control, Crossover Assignment

Further study details as provided by Ohio State University:

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	9 Years to 30 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Ages of 9 to 30

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472407

Locations

United States, Ohio
The Ohio State University College of Optometry
Columbus, Ohio, United States, 43210

Sponsors and Collaborators

Ohio State University

Investigators

Principal Investigator:

Marjean Kulp, OD, MS

Ohio State University

More Information

Study ID Numbers:	2004H0161
Study First Received:	May 9, 2007
Last Updated:	July 1, 2008
ClinicalTrials.gov Identifier:	NCT00472407
Health Authority:	United States: Institutional Review Board

Keywords provided by Ohio State University:

Normal

Study placed in the following topic categories:

Ocular Motility Disorders
Motor neuro-ophthalmic disorders
Eye Diseases
Central Nervous System Diseases
Ocular motility disorders

Additional relevant MeSH terms:

Nervous System Diseases
Cranial Nerve Diseases

ClinicalTrials.gov processed this record on January 14, 2009